CA2476771A1 - A preparation and method for weight reduction - Google Patents

A preparation and method for weight reduction Download PDF

Info

Publication number
CA2476771A1
CA2476771A1 CA002476771A CA2476771A CA2476771A1 CA 2476771 A1 CA2476771 A1 CA 2476771A1 CA 002476771 A CA002476771 A CA 002476771A CA 2476771 A CA2476771 A CA 2476771A CA 2476771 A1 CA2476771 A1 CA 2476771A1
Authority
CA
Canada
Prior art keywords
amino acids
trypsin
essential amino
trypsin inhibitor
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002476771A
Other languages
English (en)
French (fr)
Inventor
Pia Heino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
REMEDAL Oy
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2476771A1 publication Critical patent/CA2476771A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/56—Protease inhibitors from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
CA002476771A 2002-02-20 2003-02-12 A preparation and method for weight reduction Abandoned CA2476771A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20020332 2002-02-20
FI20020332A FI109970B (fi) 2002-02-20 2002-02-20 Valmiste ja menetelmä painon pudottamiseksi
PCT/FI2003/000107 WO2003070276A1 (en) 2002-02-20 2003-02-12 A preparation and method for weight reduction

Publications (1)

Publication Number Publication Date
CA2476771A1 true CA2476771A1 (en) 2003-08-28

Family

ID=8563269

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002476771A Abandoned CA2476771A1 (en) 2002-02-20 2003-02-12 A preparation and method for weight reduction

Country Status (11)

Country Link
US (1) US20050096266A1 (https=)
EP (1) EP1482976B1 (https=)
JP (1) JP2005523284A (https=)
CN (1) CN1729017A (https=)
AT (1) ATE405290T1 (https=)
AU (1) AU2003205795A1 (https=)
CA (1) CA2476771A1 (https=)
DE (1) DE60323062D1 (https=)
ES (1) ES2314175T3 (https=)
FI (1) FI109970B (https=)
WO (1) WO2003070276A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080268038A1 (en) * 2007-04-26 2008-10-30 Wolfe Robert R Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength
EP2067411A1 (en) * 2007-11-29 2009-06-10 Paolo Oddenino Paris S.R.L. Food composition usable as substitute meal

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB652237A (en) * 1945-12-27 1951-04-18 Merck & Co Inc Therapeutic amino acid mixtures
US4042687A (en) * 1975-11-24 1977-08-16 Control Drug, Inc. Method of treating obesity by the oral administration of a predigested protein composition
US4491578A (en) * 1982-06-14 1985-01-01 Peikin Steven R Method of stimulating satiety in mammals
JPH0623113B2 (ja) * 1986-01-31 1994-03-30 浩 前田 癌性胸・腹水貯留抑制剤
JPH02250823A (ja) * 1989-03-24 1990-10-08 Tsumura & Co マイクロカプセル剤およびその製造方法
FI920206A0 (fi) * 1992-01-17 1992-01-17 Pekka Untamo Heino Medicinsk anvaendning, medicinskt foerfarande och preparat.
ES2087027B1 (es) * 1994-08-03 1997-02-01 Univ Illes Balears Suplementos nutricionales termogeneticos, alimentos que los contienen y aplicaciones.
IT1320782B1 (it) * 2000-07-04 2003-12-10 Professional Dietetics Srl Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca.
JP2002154976A (ja) * 2000-11-22 2002-05-28 Sanpo Kk 慢性疾患の予防、改善及び／又は治療剤並びに健康食品

Also Published As

Publication number Publication date
EP1482976A1 (en) 2004-12-08
DE60323062D1 (de) 2008-10-02
WO2003070276A1 (en) 2003-08-28
AU2003205795A1 (en) 2003-09-09
FI20020332A0 (fi) 2002-02-20
JP2005523284A (ja) 2005-08-04
EP1482976B1 (en) 2008-08-20
ES2314175T3 (es) 2009-03-16
CN1729017A (zh) 2006-02-01
FI109970B (fi) 2002-11-15
ATE405290T1 (de) 2008-09-15
US20050096266A1 (en) 2005-05-05

Similar Documents

Publication Publication Date Title
US20040018190A1 (en) Drugs and foods improving the quality of life and process for producing the same
JP3668241B2 (ja) 脂質代謝改善用組成物
CA2476984C (en) Lactoferrin as an agent for enhancing action of an opioid
CN1326561C (zh) 肝病、高血脂症和糖尿病治疗剂
KR20000023819A (ko) 식욕억제
US9023408B2 (en) Composition and method for control of diabetes
CN120112280A (zh) 用于口服递送的组合物
JPH08503964A (ja) 食餌療法の低コレステロール血組成物
EP1482976B1 (en) A preparation and method for weight reduction
JP2014524743A (ja) 多成分栄養系
AU2006259224B2 (en) Composition and method for inhibiting, preventing, or ameliorating complications associated with ingestion of a medicinal, chemical, or biological substance or agent
CN119212574B (zh) 用于降低血糖的水解胶原蛋白
CN105982905A (zh) 20(R)-人参皂苷Rg3在制备预防或/和治疗肥胖症药物中的应用及药物
JP2010248219A (ja) 生活の質を改善する新規医薬組成物ならびに新規食品の製法および用途
CN115606808A (zh) 有助于预防和控制肥胖的膳食组合物
US20100016210A1 (en) Sensotherapy
CN102283832B (zh) 一种预防或治疗高血压肥胖患者的药物组合物及用途
JP2005239737A (ja) 生活の質を改善する新規医薬組成物の製法および用途
JP3537098B2 (ja) アルコール性肝障害軽減剤
JP2010510310A (ja) コウジカビプロテアーゼを使用する処置の方法
CN111011850A (zh) 一种含有植物甾醇的组合物的用途
Schatz et al. Role of Pancreatic Enzyme Therapy in Pancreatic Exocrine Insufficiency
WO2025119939A1 (en) Treatment of obesity and related conditions by circadian administration of enterokine-stimulating compositions
Graham Treatment of steatorrhea in chronic pancreatitis
WO2022029029A1 (en) Composition and method for modulating food intake

Legal Events

Date Code Title Description
FZDE Discontinued